Results 171 to 180 of about 6,192,922 (341)
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Using context mapping for planning implementation of movement behavior change in physiotherapy. [PDF]
van Rongen S +8 more
europepmc +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source
Hypothetical nudges provide directional but noisy estimates of real behavior change. [PDF]
Gandhi L +3 more
europepmc +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source
Feasibility trial of a transdiagnostic individual lifestyle evaluation and intervention (Lev-i) for health behavior change. [PDF]
Sjöwall D +4 more
europepmc +1 more source
Phase behavior of hard rods between two walls: Phase change of particles without occurring phase transition [PDF]
Roohollah Aliabadi +2 more
openalex +1 more source
Mental Health, Behavior Change Skills, and Eating Behaviors in Postpartum Women
Yang Yu +3 more
openalex +2 more sources
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard +5 more
wiley +1 more source
Preventive Behaviors of French Cancer Patients and How They Changed During the COVID-19 Outbreak (PAPESCO-19 Study) [PDF]
Paul-Rémi Petit +9 more
openalex +1 more source

